Basic Information
| RNALocate ID: | RLID:11002765 |
| RNA Symbol: | hsa-miR-448 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-448 |
| RNA ID: | miRBase:MIMAT0001532 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 18589210 |
| Tissue/Cell Line: | Serum |
| Method: | Microarray |
| Description: | Association of microRNA with peripheral blood-derived tumor exosomes compared with microRNA isolated from their corresponding tumors. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11002766 | Exosome | Brain tissue | 23382797 |
| RLID:11002767 | Exosome | Plasma | 23663360 |
| RLID-D:11001226 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
| RLID-D:11003932 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-448 | Medulloblastoma | MNDR-E-MI-50563 |
| MNDR | hsa-miR-448 | Estrogen-receptor positive breast cancer | MNDR-E-MI-50564 |
| MNDR | hsa-miR-448 | Estrogen-receptor negative breast cancer | MNDR-E-MI-50565 |
| MNDR | hsa-miR-448 | Progesterone-receptor positive breast cancer | MNDR-E-MI-50566 |
| MNDR | hsa-miR-448 | Progesterone-receptor negative breast cancer | MNDR-E-MI-50567 |
| MNDR | hsa-miR-448 | Her2-receptor positive breast cancer | MNDR-E-MI-50568 |
| MNDR | hsa-miR-448 | Gastric cancer | MNDR-E-MI-50569 |
| MNDR | hsa-mir-448 | Stomach cancer | MNDR-E-MI-50570 |
| MNDR | hsa-miR-448 | Alzheimer disease | MNDR-E-MI-50571 |
| MNDR | hsa-miR-448 | Huntington disease | MNDR-E-MI-50572 |
| MNDR | hsa-mir-448 | Huntington disease | MNDR-E-MI-50573 |
| MNDR | hsa-miR-448 | Chorea | MNDR-E-MI-50574 |
| MNDR | hsa-miR-448 | Lung cancer | MNDR-E-MI-50575 |
| MNDR | hsa-miR-448 | Parkinson disease | MNDR-E-MI-50576 |
| MNDR | hsa-miR-448 | Breast cancer | MNDR-E-MI-50577 |
| MNDR | hsa-mir-448 | Breast cancer | MNDR-E-MI-50578 |
| MNDR | hsa-miR-448 | Pancreatic cancer | MNDR-E-MI-50579 |
| MNDR | hsa-mir-448 | Hepatitis C | MNDR-E-MI-50580 |
| MNDR | hsa-miR-448 | Melanoma | MNDR-E-MI-50581 |
| MNDR | hsa-miR-448 | Colon cancer | MNDR-E-MI-50582 |
| MNDR | hsa-mir-448 | Ovarian cancer | MNDR-E-MI-50583 |
| MNDR | hsa-miR-448 | Glioblastoma | MNDR-E-MI-50584 |
| MNDR | hsa-miR-448 | Malignant glioma | MNDR-E-MI-50585 |
| MNDR | hsa-miR-448 | Amyotrophic lateral sclerosis | MNDR-E-MI-50586 |
| MNDR | hsa-mir-448 | Osteosarcoma | MNDR-E-MI-50587 |
| MNDR | hsa-mir-448 | Pancreatic ductal adenocarcinoma | MNDR-E-MI-50588 |
| MNDR | hsa-mir-448 | Lung squamous cell carcinoma | MNDR-E-MI-50589 |
| MNDR | hsa-mir-448 | Carcinoma hepatocellular | MNDR-E-MI-50590 |
| MNDR | hsa-miR-448 | Embryonal cancer | MNDR-E-MI-50591 |
| MNDR | hsa-miR-448 | Malignant pleural mesothelioma | MNDR-E-MI-50592 |
| MNDR | hsa-miR-448 | Hodgkin disease | MNDR-E-MI-50593 |
| MNDR | hsa-miR-448 | Tonsil cancer | MNDR-E-MI-50594 |
| MNDR | hsa-miR-448 | Colorectal cancer | MNDR-E-MI-50595 |
| MNDR | hsa-mir-448 | Colorectal cancer | MNDR-E-MI-50596 |
| MNDR | hsa-miR-448 | Nasopharynx carcinoma | MNDR-E-MI-50597 |
| MNDR | hsa-miR-448 | Multiple myeloma | MNDR-E-MI-50598 |
| MNDR | hsa-miR-448 | Nasopharyngeal cancer | MNDR-E-MI-50599 |
| MNDR | hsa-miR-448 | Breast cancer her3+ negative | MNDR-E-MI-50600 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAM10 | Homo sapiens | RR00040155 |
TOP